-
Liantuo Biotechnology, which refuses to "sell themselves": both CEO and CFO have resigned and have sold celebrity products to earn price differences
Within two days, the CEO and CFO of Lian Biotech (LIAN. US) left one after another. On December 19th local time in the United States, Liantuo Biotechnology announced on its official website that its ... -
AstraZeneca will acquire Genxi Biotechnology with a transaction value of approximately $1.2 billion
On December 26, AstraZeneca China WeChat official account announced that AstraZeneca had signed a final agreement on the acquisition proposal of Genxi Biology. This proposed acquisition will add GC01 ... -
Previously refused to be acquired, now Liantuo Biotechnology will close its business and delist
Lian Tuo Biotechnology (LIAN.US), which had previously rejected a tender offer from Concentrate, has now decided to directly close its business and delist. On February 13th, Liantuo Biotechnology ann ... -
Abbey and Mingji Biotechnology sign a license agreement to jointly develop FG-M701
Abbott announced recently that it has signed a licensing agreement with Mingji Biotechnology to jointly develop the next generation TL1A antibody FG-M701 for the treatment of inflammatory bowel disea ...